Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Sabine C. Linn
Based on 97 articles published since 2009
(Why 97 articles?)
||||
Expertise Level
The expertise of Sabine C. Linn ranks in the
  • Top 0.036%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 97 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Linn, Sabine C   ·   Linn, Sabine   ·   Linn, S C
Work Locations
Details
Most likely:    Leeuwenhoek Hospital      
2019
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Utrecht, the Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, Ghent University Hospital, Ghent, Belgium. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · NanoString Technologies, Inc., Seattle, WA, USA. · Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia. · Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 31086347
  • Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. · Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organization IKNL, Utrecht, The Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands. · Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Sittard, The Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Heerlen, The Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands. · Pubmed 30588619
  • Clinical Trials and Statistics Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. · Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Department of Medical Onology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Pubmed 30680659
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands. · Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands. · Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands. · Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: · Pubmed 30413379
  • Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Data Centre, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Dutch Breast Cancer Research Group, BOOG Study Centre, IJsbaanpad 9-11, 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Deventer Ziekenhuis, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands. · Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545 AA, The Hague, The Netherlands. · Department of Internal Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Medical Oncology, Zaans Medisch Centrum, Koningin Julianaplein 58, 1502 DV, Zaandam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Centre, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: · Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands. · Pubmed 30125761
  • Department of Pathology, University Medical Center Utrecht, The Netherlands. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto, Portugal. · Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Portugal. · Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands. · Pubmed 29972720
  • Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Groep, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Centre Utrecht, and Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Pubmed 30287915
  • Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Departments of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, University Hospital Antwerpen, Edegem, Belgium. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Pubmed 30041599
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Hpn Q05.4300, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization, PO Box 19079, 3501 DB, Utrecht, The Netherlands; Department of Health Technology & Services Research (HTSR), University of Twente, PO Box 217, Enschede 7500 AE, Enschede, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 29274928
2017
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 28616845
  • Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., P.O. Box 19024, Seattle, USA. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX Utrecht, The Netherlands; Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. Electronic address: · Pubmed 27992844
  • Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. Electronic address: · Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. · Department for Health Evidence, Radboud Institute Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, Netherlands. · Department of Medical Oncology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands. · Department of Medical Oncology, Medical Centre Leeuwarden, Leeuwarden, Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Sittard-Geleen, Geleen, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Heerlen, Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. · Pubmed 29031778
  • Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. · Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. · Division of Surgical Oncology, Diakonessenhuis Hospital, Utrecht, the Netherlands. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Surgical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands. · Department of Radiation Oncology, Maastricht University Medical Centre (MAASTRO clinic), Maastricht, the Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands. · Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. · Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands. · Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands. · Radiation Oncology, Radiotherapy group, Arnhem, the Netherlands. · Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, the Netherlands. · Division of Surgical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. · Pubmed 28668073
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Surgery; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091 AC Amsterdam, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 3-11, 2625 AD Delft, The Netherlands. · Department of Medical Oncology, Medical Centre Haaglanden, Lijnbaan 32, 2512 VA The Hague, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 28335887
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28017458
  • Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. · Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organisation IKNL, Utrecht, the Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands. · Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, the Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Sittard, the Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Heerlen, the Netherlands. · Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, the Netherlands. · Pubmed 29546343
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands. · Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland. · Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, Gelderland, Netherlands. · Department of Pathology, ErasmusMC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain. · Department of Pathology, IsalaKlinieken Zwolle, Zwolle, Overijssel, Netherlands. · Department of Pathology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands. · Department of Pathology, Rion University Hospital, University of Patras, Medical School, Patras, Greece. · Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Piemonte, Italy. · Department of Medical Sciences, University of Torino, Torino, Italy. · Department of Tumor Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland. · Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Kralove, Czech Republic. · Departmentof Obstetrics and Gynaecology at the Catholic, Universityof Leuven, Leuven, Belgium. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, NetherlandsCancer Institute, Amsterdam, Noord-Holland, Netherlands. · Genomics Core Facility, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Medical Image Analysis Group (IMAG/e), Technische Universiteit Eindhoven, Eindhoven, Noord-Brabant, Netherlands. · Department of Epidemiology, Maastricht University, Maastricht, Limburg, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, Utrecht, UK. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Computational Cancer Biology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, Overijssel, Netherlands. · Pubmed 29138205
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Netherlands Cancer Institute, Amsterdam, The Netherlands. · German Breast Group, Neu-Isenburg, Germany. · Charité - Universitätsmedizin, Berlin, Germany. · University Women's Hospital, Frankfurt, Germany. · University Clinic for Internal Medicine Oncology and Hematology, Oldenburg, Germany. · University Halle Wittenberg, Halle, Germany. · Gesellschaft für onkologische Studien, Troisdorf, Germany. · St. Josefs-Hospital, Wiesbaden, Germany. · Ev. Krankenhaus, Ludwigsfelde-Teltow, Germany. · Elisabeth Krankenhaus, Kassel, Germany. · Women's Hospital, University of Kiel, Kiel, Germany. · University Medical Center, Utrecht, The Netherlands. · Center for Gynecological Oncology at University Women's Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Pubmed 28822007
  • Anne Kuijer, Marieke Straver, Bianca den Dekker, Annelotte C.M. van Bommel, and Thijs van Dalen, Diakonessenhuis · Anne Kuijer, Sjoerd G. Elias, Sabine C. Linn, and Thijs van Dalen, University Medical Centre Utrecht · Sabine Siesling, Netherlands Comprehensive Cancer Organization, Utrecht · Carolien H. Smorenburg and Jelle Wesseling, Antoni van Leeuwenhoek Hospital · Carolien H. Smorenburg, Jelle Wesseling, Sabine C. Linn, and Emiel J.Th. Rutgers, Netherlands Cancer Institute, Amsterdam · and Sabine Siesling, University of Twente, Enschede, the Netherlands. · Pubmed 28813638
  • Center for Reproductive Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Center for Reproductive Medicine, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: · Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands. · Center for Reproductive Medicine, UZ Brussel, Free University of Brussels, Belgium. · Department of Reproductive Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Reproductive Medicine, VU University Medical Center, Amsterdam, The Netherlands. · Department of Reproductive Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Obstetrics and Gynaecology, St Elisabeth Hospital, Tilburg, The Netherlands. · Department of Gynaecology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Obstetrics and Gynaecology, University Medical Center Groningen, Groningen, The Netherlands. · Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, Jeroen Bosch Hospital, Den Bosch, The Netherlands. · Assisted Conception Unit, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 28710053
  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. · Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland. · Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. · OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland. · Lund University, Lund, Sweden. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28455421
  • Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Faculty of Medical Science, Anglia Ruskin University, Cambridge, UK. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Epidemiology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Laboratory Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · University of Texas, Health Sciences Center, San Antonio, USA. · Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, UK. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28412587
  • Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Pubmed 28167798
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Biometrics, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Moores Cancer Center, University of California San Diego, San Diego, CA, USA. · Department of Pathology, University Medical Center, Utrecht, The Netherlands. · Laboratory Medicine, University of California, San Francisco, CA, USA. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 28005246
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Department of Medical Oncology, Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands. · Department of Medical Oncology, Ikazia Hospital, Rotterdam, the Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Comprehensive Cancer Center of the Netherlands, Amsterdam, the Netherlands. · Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands. · Department of Medical Oncology, Leeuwarden Medical Center, Leeuwarden, the Netherlands. · Department of Medical Oncology, Haga Hospital, the Hague, the Netherlands. · Department of Medical Oncology, Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands. · Department of Medical Oncology, Isala Clinic, Zwolle, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Orbis Medical Center, Sittard, the Netherlands. · Department of Medical Oncology, Sint Franciscus Gasthuis, Rotterdam, the Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, the Netherlands. · Department of Medical, Oncology, Vlietland Hospital, Schiedam, the Netherlands. · Dutch Breast Cancer Research Group, Amsterdam, the Netherlands. · Pubmed 27315546
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · West German Study Group, Germany. · Breast Centre Niederrhein, Moenchengladbach, Germany. · Brustzentrum, Ludwig-Maximillian University Munich, Germany. · Universitäts-Frauenklinik Duesseldorf, Germany. · Genomics Core Facility, NKI-AVL, Amsterdam, The Netherlands. · Universitäts-Frauenklinik Lübeck, Germany. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Germany. · National Center for Tumour Diseases, University of Heidelberg, Germany. · Pubmed 26946057
  • Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Statistics Department, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Academical Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 27587341
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Isala, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD Delft, The Netherlands. · Department of Medical Oncology, Ziekenhuisgroep Twente, Zilvermeeuw 1, 7609 PP Almelo, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 27498129
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511DT, Utrecht, The Netherlands. · Department of Molecular Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27357813
  • Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands. · Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. · Department of Radiation Oncology, Medical Spectrum Twente, Enschede, Netherlands. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Utrecht, Netherlands. · Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands. · Department of Surgical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, Netherlands. Electronic address: · Pubmed 27344114
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27197147
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Agendia NV, Amsterdam, XH, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Pathology, University Medical Center Utrecht, CX, The Netherlands. · Pubmed 27129152
  • Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Agendia Inc, 22 Morgan, Irvine, CA 92618, USA. · Divisions of Molecular Pathology and Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Pubmed 27002507
  • Erasmus University Medical Center Rotterdam , Erasmus MC Cancer Institute, Department of Medical Oncology, 3015 CN Rotterdam, The Netherlands. · Postgraduate School of Molecular Medicine, Erasmus University Medical Center , 3015 CN Rotterdam, The Netherlands. · Broad Institute of MIT and Harvard , Cambridge, Massachusetts 02142, United States. · Erasmus University Medical Center Rotterdam , Department of Neurology, 3015 CN Rotterdam, The Netherlands. · Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Medical Oncology, 1066 CX Amsterdam, The Netherlands. · Radboud University Medical Center , Department of Laboratory Medicine, 6525 GA Nijmegen, The Netherlands. · Radboud University Medical Center , Department of Radiation Oncology, 6525 GA Nijmegen, The Netherlands. · Pubmed 26958999
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands. · Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. · Pubmed 26657294
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · MRC Holland, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 26637364
  • Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands. · Department of Medical Oncology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Laboratory for Pathology Dordrecht, Dordrecht, The Netherlands. · Department of Surgery, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 26583684
  • Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Department of Laboratory Medicine, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: · Department of Radiation Oncology, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: · Department of Pathology, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands. Electronic address: · Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Pubmed 26285647
  • Department of Neuro-oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Neuro-oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 26732082
2015
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam, and University Medical Center Utrecht, Utrecht, the Netherlands · Pubmed 25918281
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, Netherlands. · Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, Netherlands. · Pubmed 26196252
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Pubmed 26429398
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 26355282
  • Division of Surgical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Department of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800 6202 AZ, Maastricht, The Netherlands. · Division of Surgical Oncology, Radboud university medical centre, Nijmegen, The Netherlands. · Division of Surgical Oncology, Diakonessenhuis Hospital, Utrecht, The Netherlands. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Surgical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands. · Department of Radiation Oncology, Maastricht University Medical Centre (MAASTRO clinic), Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Department of Radiation Oncology, Radboud university medical centre, Nijmegen, The Netherlands. · Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands. · Radiation Oncology, Arnhem Institute for Radiation Oncology, Arnhem, The Netherlands. · Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands. · Division of Surgical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Pubmed 26335105
  • Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Division of Cell Biology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Cell Biology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 26272591
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands. Electronic address: · Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium; Department of Medical Oncology, University Hospital Antwerp, Wilrijkstraat 10, B2650 Antwerp, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands. · Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Marseille Cancer Research Center (CRCM), UMR891 Inserm, Institut Paoli-Calmettes (IPC), Department of Molecular Oncology, Marseille, France. · Research and Development, Agendia BV, Amsterdam, The Netherlands. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium. · Department of Medical Oncology, University Hospital Antwerp, Wilrijkstraat 10, B2650 Antwerp, Belgium. · Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium. · Pubmed 25771305
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Heidelberg, Germany. National Center for Tumour Diseases, Heidelberg, Germany. · Institute of Pathology, University of Heidelberg, Heidelberg, Germany. · Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 25480832
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University Medical Center Utrecht, Utrecht, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University of Twente, School of Governance and Management, Enschede, the Netherlands · Pubmed 25847931
2014
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Catharina Ziekenhuis, Eindhoven, The Netherlands. · Department of Medical Oncology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Surgery, MC Zuiderzee, Lelystad, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Pubmed 24970786
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Hospital René Huguenin, Institut Curie, 35 Rue Dailly, 92210 Saint-Cloud, France. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Center, Univ. Bordeaux, INSERM U916, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Breast Cancer Unit, Champalimaud Cancer Center, Avenida Brasília, 1400-038 Lisbon, Portugal. · Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany. · Department of Internal Medicine, Isala Klinieken, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands. · Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ University of Amsterdam, The Netherlands. · Department of Internal Medicine, HAGA Hospital, Leyweg 275, 2545 CH Den Haag, The Netherlands. · Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. · Department of Internal Medicine, Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 24529927
  • Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: · Department of Research and Development, Agendia, Amsterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Product Development and Support, Agendia, Amsterdam, the Netherlands. · Department of Medical Affairs, Agendia, Irvine, California. · Department of Medical Affairs, Agendia, Amsterdam, the Netherlands. · Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgical Oncology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Pathology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Medicine, Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, California. · Department of Surgery, University of South Florida, Tampa, Florida. · Pubmed 24378251
2015
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Pubmed 25940823
  • Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 26210520
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
2014
  • Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24859000
  • Department of Surgical Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands. · Pubmed 24760482
  • Department of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 24501006
  • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24390246
2013
  • Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 23972475
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 23545365
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23682812
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. · Pubmed 24373320
  • Authors' Affiliations: Department of Medical Oncology, Erasmus University Medical Center, Cancer Institute, Rotterdam; Departments of Molecular Carcinogenesis and Molecular Pathology, Central Genomic Facility, the Netherlands Cancer Institute; Agendia NV, Amsterdam, the Netherlands; and Translational Cancer Research Unit, Laboratory of Pathology, Antwerp University/Oncology Centre, GZA Hospitals St-Augustinus, Antwerp, Belgium. · Pubmed 24242068
  • Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066, The Netherlands. · Pubmed 24149178
  • Netherlands Cancer Institute (NKI-AVL), Department of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands. · Pubmed 23992641
  • Department of Molecular Biology and Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 23736997
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 23670131
  • Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23371464
2012
  • Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 22825374
  • Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Pubmed 22894140
Probable:    Universiteit Utrecht      
2019
  • Clinical Trials and Statistics Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. · Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Department of Medical Onology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Pubmed 30680659
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands. · Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands. · Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands. · Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: · Pubmed 30413379
  • Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Data Centre, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Dutch Breast Cancer Research Group, BOOG Study Centre, IJsbaanpad 9-11, 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Deventer Ziekenhuis, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands. · Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545 AA, The Hague, The Netherlands. · Department of Internal Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Medical Oncology, Zaans Medisch Centrum, Koningin Julianaplein 58, 1502 DV, Zaandam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Centre, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: · Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands. · Pubmed 30125761
  • Department of Pathology, University Medical Center Utrecht, The Netherlands. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto, Portugal. · Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Portugal. · Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands. · Pubmed 29972720
  • Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Groep, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Centre Utrecht, and Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Pubmed 30287915
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Hpn Q05.4300, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization, PO Box 19079, 3501 DB, Utrecht, The Netherlands; Department of Health Technology & Services Research (HTSR), University of Twente, PO Box 217, Enschede 7500 AE, Enschede, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 29274928
2017
  • Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., P.O. Box 19024, Seattle, USA. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX Utrecht, The Netherlands; Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. Electronic address: · Pubmed 27992844
  • Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. Electronic address: · Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. · Department for Health Evidence, Radboud Institute Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, Netherlands. · Department of Medical Oncology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands. · Department of Medical Oncology, Medical Centre Leeuwarden, Leeuwarden, Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Sittard-Geleen, Geleen, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Heerlen, Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. · Pubmed 29031778
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28017458
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands. · Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland. · Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, Gelderland, Netherlands. · Department of Pathology, ErasmusMC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain. · Department of Pathology, IsalaKlinieken Zwolle, Zwolle, Overijssel, Netherlands. · Department of Pathology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands. · Department of Pathology, Rion University Hospital, University of Patras, Medical School, Patras, Greece. · Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Piemonte, Italy. · Department of Medical Sciences, University of Torino, Torino, Italy. · Department of Tumor Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland. · Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Kralove, Czech Republic. · Departmentof Obstetrics and Gynaecology at the Catholic, Universityof Leuven, Leuven, Belgium. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, NetherlandsCancer Institute, Amsterdam, Noord-Holland, Netherlands. · Genomics Core Facility, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Medical Image Analysis Group (IMAG/e), Technische Universiteit Eindhoven, Eindhoven, Noord-Brabant, Netherlands. · Department of Epidemiology, Maastricht University, Maastricht, Limburg, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, Utrecht, UK. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Computational Cancer Biology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, Overijssel, Netherlands. · Pubmed 29138205
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Netherlands Cancer Institute, Amsterdam, The Netherlands. · German Breast Group, Neu-Isenburg, Germany. · Charité - Universitätsmedizin, Berlin, Germany. · University Women's Hospital, Frankfurt, Germany. · University Clinic for Internal Medicine Oncology and Hematology, Oldenburg, Germany. · University Halle Wittenberg, Halle, Germany. · Gesellschaft für onkologische Studien, Troisdorf, Germany. · St. Josefs-Hospital, Wiesbaden, Germany. · Ev. Krankenhaus, Ludwigsfelde-Teltow, Germany. · Elisabeth Krankenhaus, Kassel, Germany. · Women's Hospital, University of Kiel, Kiel, Germany. · University Medical Center, Utrecht, The Netherlands. · Center for Gynecological Oncology at University Women's Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Pubmed 28822007
  • Anne Kuijer, Marieke Straver, Bianca den Dekker, Annelotte C.M. van Bommel, and Thijs van Dalen, Diakonessenhuis · Anne Kuijer, Sjoerd G. Elias, Sabine C. Linn, and Thijs van Dalen, University Medical Centre Utrecht · Sabine Siesling, Netherlands Comprehensive Cancer Organization, Utrecht · Carolien H. Smorenburg and Jelle Wesseling, Antoni van Leeuwenhoek Hospital · Carolien H. Smorenburg, Jelle Wesseling, Sabine C. Linn, and Emiel J.Th. Rutgers, Netherlands Cancer Institute, Amsterdam · and Sabine Siesling, University of Twente, Enschede, the Netherlands. · Pubmed 28813638
  • Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Faculty of Medical Science, Anglia Ruskin University, Cambridge, UK. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Epidemiology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Laboratory Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · University of Texas, Health Sciences Center, San Antonio, USA. · Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, UK. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28412587
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Biometrics, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Moores Cancer Center, University of California San Diego, San Diego, CA, USA. · Department of Pathology, University Medical Center, Utrecht, The Netherlands. · Laboratory Medicine, University of California, San Francisco, CA, USA. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 28005246
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · West German Study Group, Germany. · Breast Centre Niederrhein, Moenchengladbach, Germany. · Brustzentrum, Ludwig-Maximillian University Munich, Germany. · Universitäts-Frauenklinik Duesseldorf, Germany. · Genomics Core Facility, NKI-AVL, Amsterdam, The Netherlands. · Universitäts-Frauenklinik Lübeck, Germany. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Germany. · National Center for Tumour Diseases, University of Heidelberg, Germany. · Pubmed 26946057
  • Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Statistics Department, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Academical Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 27587341
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511DT, Utrecht, The Netherlands. · Department of Molecular Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27357813
  • Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands. · Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. · Department of Radiation Oncology, Medical Spectrum Twente, Enschede, Netherlands. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Utrecht, Netherlands. · Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands. · Department of Surgical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, Netherlands. Electronic address: · Pubmed 27344114
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Agendia NV, Amsterdam, XH, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Pathology, University Medical Center Utrecht, CX, The Netherlands. · Pubmed 27129152
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · MRC Holland, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 26637364
2015
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam, and University Medical Center Utrecht, Utrecht, the Netherlands · Pubmed 25918281
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Pubmed 26429398
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 26355282
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Heidelberg, Germany. National Center for Tumour Diseases, Heidelberg, Germany. · Institute of Pathology, University of Heidelberg, Heidelberg, Germany. · Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 25480832
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University Medical Center Utrecht, Utrecht, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University of Twente, School of Governance and Management, Enschede, the Netherlands · Pubmed 25847931
2014
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Catharina Ziekenhuis, Eindhoven, The Netherlands. · Department of Medical Oncology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Surgery, MC Zuiderzee, Lelystad, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Pubmed 24970786
  • Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: · Department of Research and Development, Agendia, Amsterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Product Development and Support, Agendia, Amsterdam, the Netherlands. · Department of Medical Affairs, Agendia, Irvine, California. · Department of Medical Affairs, Agendia, Amsterdam, the Netherlands. · Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgical Oncology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Pathology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Medicine, Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, California. · Department of Surgery, University of South Florida, Tampa, Florida. · Pubmed 24378251
2015
  • Universitair Medisch Centrum Utrecht, afd. Chirurgie, Utrecht. · Pubmed 26131746
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 97 total) written by Sabine C. Linn about Breast Neoplasms:

  • Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. 2019
  • Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure. 2019
  • Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES. 2019
  • PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer. 2018
  • Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial. 2018
  • Adjuvant dose-dense doxorubicin-cyclophosphamide versus docetaxel-doxorubicin-cyclophosphamide for high-risk breast cancer: First results of the randomised MATADOR trial (BOOG 2004-04). 2018
  • FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome. 2018
  • Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences. 2018
  • Mitotic count can predict tamoxifen benefit in postmenopausal breast cancer patients while Ki67 score cannot. 2018
  • Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer. 2018
Show List of Full Article Records
Google Searches

Learn more about Sabine C. Linn using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Leeuwenhoek Hospital
Universiteit Utrecht
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Leeuwenhoek Hospital
2019
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Oncode Institute, Utrecht, the Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, Ghent University Hospital, Ghent, Belgium. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · NanoString Technologies, Inc., Seattle, WA, USA. · Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium. · Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia. · Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 31086347
  • Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. · Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organization IKNL, Utrecht, The Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands. · Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Sittard, The Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Heerlen, The Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, The Netherlands. · Pubmed 30588619
  • Clinical Trials and Statistics Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. · Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Department of Medical Onology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Pubmed 30680659
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands. · Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands. · Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands. · Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: · Pubmed 30413379
  • Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Data Centre, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Dutch Breast Cancer Research Group, BOOG Study Centre, IJsbaanpad 9-11, 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Deventer Ziekenhuis, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands. · Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545 AA, The Hague, The Netherlands. · Department of Internal Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Medical Oncology, Zaans Medisch Centrum, Koningin Julianaplein 58, 1502 DV, Zaandam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Centre, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: · Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands. · Pubmed 30125761
  • Department of Pathology, University Medical Center Utrecht, The Netherlands. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto, Portugal. · Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Portugal. · Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands. · Pubmed 29972720
  • Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Groep, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Centre Utrecht, and Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Pubmed 30287915
  • Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Departments of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, University Hospital Antwerpen, Edegem, Belgium. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. · Pubmed 30041599
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Hpn Q05.4300, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization, PO Box 19079, 3501 DB, Utrecht, The Netherlands; Department of Health Technology & Services Research (HTSR), University of Twente, PO Box 217, Enschede 7500 AE, Enschede, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 29274928
2017
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 28616845
  • Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., P.O. Box 19024, Seattle, USA. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX Utrecht, The Netherlands; Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. Electronic address: · Pubmed 27992844
  • Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. Electronic address: · Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. · Department for Health Evidence, Radboud Institute Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, Netherlands. · Department of Medical Oncology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands. · Department of Medical Oncology, Medical Centre Leeuwarden, Leeuwarden, Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Sittard-Geleen, Geleen, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Heerlen, Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. · Pubmed 29031778
  • Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. · Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. · Division of Surgical Oncology, Diakonessenhuis Hospital, Utrecht, the Netherlands. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Surgical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands. · Department of Radiation Oncology, Maastricht University Medical Centre (MAASTRO clinic), Maastricht, the Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands. · Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. · Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands. · Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands. · Radiation Oncology, Radiotherapy group, Arnhem, the Netherlands. · Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, the Netherlands. · Division of Surgical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands. · Pubmed 28668073
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Surgery; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Oosterpark 9, 1091 AC Amsterdam, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 3-11, 2625 AD Delft, The Netherlands. · Department of Medical Oncology, Medical Centre Haaglanden, Lijnbaan 32, 2512 VA The Hague, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 28335887
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28017458
  • Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. · Biostatistics, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organisation IKNL, Utrecht, the Netherlands. · Department of Internal Medicine, Medical Center Alkmaar, Alkmaar, the Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands. · Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, the Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Sittard, the Netherlands. · Department of Medical Oncology, Zuyderland Medical Center, Heerlen, the Netherlands. · Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, the Netherlands. · Pubmed 29546343
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands. · Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland. · Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, Gelderland, Netherlands. · Department of Pathology, ErasmusMC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain. · Department of Pathology, IsalaKlinieken Zwolle, Zwolle, Overijssel, Netherlands. · Department of Pathology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands. · Department of Pathology, Rion University Hospital, University of Patras, Medical School, Patras, Greece. · Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Piemonte, Italy. · Department of Medical Sciences, University of Torino, Torino, Italy. · Department of Tumor Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland. · Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Kralove, Czech Republic. · Departmentof Obstetrics and Gynaecology at the Catholic, Universityof Leuven, Leuven, Belgium. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, NetherlandsCancer Institute, Amsterdam, Noord-Holland, Netherlands. · Genomics Core Facility, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Medical Image Analysis Group (IMAG/e), Technische Universiteit Eindhoven, Eindhoven, Noord-Brabant, Netherlands. · Department of Epidemiology, Maastricht University, Maastricht, Limburg, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, Utrecht, UK. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Computational Cancer Biology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, Overijssel, Netherlands. · Pubmed 29138205
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Netherlands Cancer Institute, Amsterdam, The Netherlands. · German Breast Group, Neu-Isenburg, Germany. · Charité - Universitätsmedizin, Berlin, Germany. · University Women's Hospital, Frankfurt, Germany. · University Clinic for Internal Medicine Oncology and Hematology, Oldenburg, Germany. · University Halle Wittenberg, Halle, Germany. · Gesellschaft für onkologische Studien, Troisdorf, Germany. · St. Josefs-Hospital, Wiesbaden, Germany. · Ev. Krankenhaus, Ludwigsfelde-Teltow, Germany. · Elisabeth Krankenhaus, Kassel, Germany. · Women's Hospital, University of Kiel, Kiel, Germany. · University Medical Center, Utrecht, The Netherlands. · Center for Gynecological Oncology at University Women's Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Pubmed 28822007
  • Anne Kuijer, Marieke Straver, Bianca den Dekker, Annelotte C.M. van Bommel, and Thijs van Dalen, Diakonessenhuis · Anne Kuijer, Sjoerd G. Elias, Sabine C. Linn, and Thijs van Dalen, University Medical Centre Utrecht · Sabine Siesling, Netherlands Comprehensive Cancer Organization, Utrecht · Carolien H. Smorenburg and Jelle Wesseling, Antoni van Leeuwenhoek Hospital · Carolien H. Smorenburg, Jelle Wesseling, Sabine C. Linn, and Emiel J.Th. Rutgers, Netherlands Cancer Institute, Amsterdam · and Sabine Siesling, University of Twente, Enschede, the Netherlands. · Pubmed 28813638
  • Center for Reproductive Medicine, Academic Medical Center, Amsterdam, The Netherlands. · Center for Reproductive Medicine, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: · Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands. · Center for Reproductive Medicine, UZ Brussel, Free University of Brussels, Belgium. · Department of Reproductive Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Reproductive Medicine, VU University Medical Center, Amsterdam, The Netherlands. · Department of Reproductive Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Obstetrics and Gynaecology, St Elisabeth Hospital, Tilburg, The Netherlands. · Department of Gynaecology, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Obstetrics and Gynaecology, University Medical Center Groningen, Groningen, The Netherlands. · Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands. · Department of Obstetrics and Gynecology, Jeroen Bosch Hospital, Den Bosch, The Netherlands. · Assisted Conception Unit, Guy's and St Thomas' Hospital NHS Foundation Trust, London, United Kingdom. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 28710053
  • UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Department of Physiology & Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland. · Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland. · Department of Molecular & Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland. · OncoMark Ltd, Belfield Innovation Park, Dublin, Ireland. · Lund University, Lund, Sweden. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, United Kingdom. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom. · Department of Medical Oncology, St. Vincent's University Hospital, Dublin, Ireland. · Institut Curie, PSL Research University, Department of Translational Research, Breast Cancer Biology Group, Paris, France. · The Netherlands Cancer Institute, Amsterdam, the Netherlands. · UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Dublin, Ireland. · Pubmed 28455421
  • Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Faculty of Medical Science, Anglia Ruskin University, Cambridge, UK. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Epidemiology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Laboratory Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · University of Texas, Health Sciences Center, San Antonio, USA. · Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, UK. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28412587
  • Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Faculty of Electrical Engineering, Mathematics, and Computer Science, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; · Pubmed 28167798
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Biometrics, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Moores Cancer Center, University of California San Diego, San Diego, CA, USA. · Department of Pathology, University Medical Center, Utrecht, The Netherlands. · Laboratory Medicine, University of California, San Francisco, CA, USA. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 28005246
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Department of Medical Oncology, Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands. · Department of Medical Oncology, Ikazia Hospital, Rotterdam, the Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Comprehensive Cancer Center of the Netherlands, Amsterdam, the Netherlands. · Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands. · Department of Medical Oncology, Leeuwarden Medical Center, Leeuwarden, the Netherlands. · Department of Medical Oncology, Haga Hospital, the Hague, the Netherlands. · Department of Medical Oncology, Erasmus Medical Center Cancer Institute and Cancer Genomics Netherlands, Rotterdam, the Netherlands. · Department of Medical Oncology, Isala Clinic, Zwolle, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands. · Department of Medical Oncology, Orbis Medical Center, Sittard, the Netherlands. · Department of Medical Oncology, Sint Franciscus Gasthuis, Rotterdam, the Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, the Netherlands. · Department of Medical, Oncology, Vlietland Hospital, Schiedam, the Netherlands. · Dutch Breast Cancer Research Group, Amsterdam, the Netherlands. · Pubmed 27315546
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · West German Study Group, Germany. · Breast Centre Niederrhein, Moenchengladbach, Germany. · Brustzentrum, Ludwig-Maximillian University Munich, Germany. · Universitäts-Frauenklinik Duesseldorf, Germany. · Genomics Core Facility, NKI-AVL, Amsterdam, The Netherlands. · Universitäts-Frauenklinik Lübeck, Germany. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Germany. · National Center for Tumour Diseases, University of Heidelberg, Germany. · Pubmed 26946057
  • Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Statistics Department, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Academical Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 27587341
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Isala, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD Delft, The Netherlands. · Department of Medical Oncology, Ziekenhuisgroep Twente, Zilvermeeuw 1, 7609 PP Almelo, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Pubmed 27498129
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511DT, Utrecht, The Netherlands. · Department of Molecular Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27357813
  • Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands. · Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. · Department of Radiation Oncology, Medical Spectrum Twente, Enschede, Netherlands. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Utrecht, Netherlands. · Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands. · Department of Surgical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, Netherlands. Electronic address: · Pubmed 27344114
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Pathology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Gynecological Oncology, University Medical Center Groningen, Groningen, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands. Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 27197147
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Agendia NV, Amsterdam, XH, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Pathology, University Medical Center Utrecht, CX, The Netherlands. · Pubmed 27129152
  • Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Agendia Inc, 22 Morgan, Irvine, CA 92618, USA. · Divisions of Molecular Pathology and Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Agendia NV, Science Park 406, 1098 XH, Amsterdam, The Netherlands. · Pubmed 27002507
  • Erasmus University Medical Center Rotterdam , Erasmus MC Cancer Institute, Department of Medical Oncology, 3015 CN Rotterdam, The Netherlands. · Postgraduate School of Molecular Medicine, Erasmus University Medical Center , 3015 CN Rotterdam, The Netherlands. · Broad Institute of MIT and Harvard , Cambridge, Massachusetts 02142, United States. · Erasmus University Medical Center Rotterdam , Department of Neurology, 3015 CN Rotterdam, The Netherlands. · Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Division of Medical Oncology, 1066 CX Amsterdam, The Netherlands. · Radboud University Medical Center , Department of Laboratory Medicine, 6525 GA Nijmegen, The Netherlands. · Radboud University Medical Center , Department of Radiation Oncology, 6525 GA Nijmegen, The Netherlands. · Pubmed 26958999
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. · Department of Pathology, Maasstad Hospital, Rotterdam, The Netherlands. · Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. · Pubmed 26657294
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · MRC Holland, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 26637364
  • Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands. · Department of Surgery, Leiden University Medical Centre, Leiden, The Netherlands. · Department of Surgery, Albert Schweitzer Hospital, Dordrecht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands. · Department of Medical Oncology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Laboratory for Pathology Dordrecht, Dordrecht, The Netherlands. · Department of Surgery, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 26583684
  • Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Department of Laboratory Medicine, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: · Department of Radiation Oncology, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: · Department of Pathology, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands. Electronic address: · Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. Electronic address: · Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: · Pubmed 26285647
  • Department of Neuro-oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Neuro-oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 26732082
2015
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam, and University Medical Center Utrecht, Utrecht, the Netherlands · Pubmed 25918281
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, Netherlands. · Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, Netherlands. · Pubmed 26196252
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Pubmed 26429398
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 26355282
  • Division of Surgical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Department of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800 6202 AZ, Maastricht, The Netherlands. · Division of Surgical Oncology, Radboud university medical centre, Nijmegen, The Netherlands. · Division of Surgical Oncology, Diakonessenhuis Hospital, Utrecht, The Netherlands. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Surgical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands. · Department of Radiation Oncology, Maastricht University Medical Centre (MAASTRO clinic), Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Department of Radiation Oncology, Radboud university medical centre, Nijmegen, The Netherlands. · Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands. · Radiation Oncology, Arnhem Institute for Radiation Oncology, Arnhem, The Netherlands. · Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, The Netherlands. · Division of Surgical Oncology, Maastricht University Medical Centre, Maastricht, The Netherlands. · GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands. · Pubmed 26335105
  • Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands. · Division of Cell Biology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Cell Biology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 26272591
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands. Electronic address: · Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium; Department of Medical Oncology, University Hospital Antwerp, Wilrijkstraat 10, B2650 Antwerp, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Wytemaweg 80, 3000 CA Rotterdam, The Netherlands. · Neurodegenerative Brain Diseases Group, Department of Molecular Genetics, VIB, Antwerp, Belgium; Institute Born-Bunge, University of Antwerp, Antwerp, Belgium. · Marseille Cancer Research Center (CRCM), UMR891 Inserm, Institut Paoli-Calmettes (IPC), Department of Molecular Oncology, Marseille, France. · Research and Development, Agendia BV, Amsterdam, The Netherlands. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium. · Department of Medical Oncology, University Hospital Antwerp, Wilrijkstraat 10, B2650 Antwerp, Belgium. · Translational Cancer Research Unit, GZA Hospitals St-Augustinus, Oosterveldlaan 24, Antwerp B2610, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium. · Pubmed 25771305
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Heidelberg, Germany. National Center for Tumour Diseases, Heidelberg, Germany. · Institute of Pathology, University of Heidelberg, Heidelberg, Germany. · Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 25480832
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University Medical Center Utrecht, Utrecht, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University of Twente, School of Governance and Management, Enschede, the Netherlands · Pubmed 25847931
2014
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Catharina Ziekenhuis, Eindhoven, The Netherlands. · Department of Medical Oncology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Surgery, MC Zuiderzee, Lelystad, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Pubmed 24970786
  • Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. · Department of Pathology, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. · Department of Bioinformatics and Statistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands. · Pubmed 25083859
  • Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Medical Oncology, Hospital René Huguenin, Institut Curie, 35 Rue Dailly, 92210 Saint-Cloud, France. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Center, Univ. Bordeaux, INSERM U916, 229 Cours de l'Argonne, 33000 Bordeaux, France. · Breast Cancer Unit, Champalimaud Cancer Center, Avenida Brasília, 1400-038 Lisbon, Portugal. · Department of Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy. · Department of Obstetrics and Gynecology, Breast Center, University of Munich, Klinikum Grosshadern, Marchioninistraße 15, 81377 Munich, Germany. · Department of Internal Medicine, Isala Klinieken, Dokter van Heesweg 2, 8025 AB Zwolle, The Netherlands. · Department of Medical Oncology, Radboud University Medical Centre, Geert Grooteplein-Zuid 10, 6525 GA Nijmegen, The Netherlands. · Department of Medical Oncology, Academic Medical Center, Meibergdreef 9, 1105 AZ University of Amsterdam, The Netherlands. · Department of Internal Medicine, HAGA Hospital, Leyweg 275, 2545 CH Den Haag, The Netherlands. · Division of Gynecologic Oncology, National Center for Tumor Diseases, University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany. · Department of Internal Medicine, Medical Center Alkmaar, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 24529927
  • Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: · Department of Research and Development, Agendia, Amsterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Product Development and Support, Agendia, Amsterdam, the Netherlands. · Department of Medical Affairs, Agendia, Irvine, California. · Department of Medical Affairs, Agendia, Amsterdam, the Netherlands. · Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgical Oncology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Pathology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Medicine, Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, California. · Department of Surgery, University of South Florida, Tampa, Florida. · Pubmed 24378251
2015
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek-The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Pubmed 25940823
  • Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 26210520
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
2014
  • Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24859000
  • Department of Surgical Oncology, Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands. · Pubmed 24760482
  • Department of Molecular Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 24501006
  • Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands, · Pubmed 24390246
2013
  • Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 23972475
  • Department of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 23545365
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23682812
  • Department of Pharmacy & Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, 1066 EC Amsterdam, The Netherlands. · Pubmed 24373320
  • Authors' Affiliations: Department of Medical Oncology, Erasmus University Medical Center, Cancer Institute, Rotterdam; Departments of Molecular Carcinogenesis and Molecular Pathology, Central Genomic Facility, the Netherlands Cancer Institute; Agendia NV, Amsterdam, the Netherlands; and Translational Cancer Research Unit, Laboratory of Pathology, Antwerp University/Oncology Centre, GZA Hospitals St-Augustinus, Antwerp, Belgium. · Pubmed 24242068
  • Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066, The Netherlands. · Pubmed 24149178
  • Netherlands Cancer Institute (NKI-AVL), Department of Psychosocial Research and Epidemiology, Amsterdam, The Netherlands. · Pubmed 23992641
  • Department of Molecular Biology and Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Pubmed 23736997
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 23670131
  • Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 23371464
2012
  • Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 22825374
  • Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Department of Psychosocial Research and Epidemiology, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands. · Pubmed 22894140
Universiteit Utrecht
2019
  • Clinical Trials and Statistics Unit (ICR-CTSU), Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, 1066CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, L69 3BX, UK. · Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, UK. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Department of Medical Onology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Cancer and Surgery, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Pubmed 30680659
2018
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pharmacy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. · Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands. · Pubmed 29063517
  • Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Reinier de Graaf Gasthuis, Delft, Netherlands. · Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands. · Department of Medical Oncology, Isala, Zwolle, Netherlands. · Department of Medical Oncology, Maxima Medical Center, Eindhoven, Netherlands. · Department of Medical Oncology, VieCuri Medical Center, Venlo, Netherlands. · Department of Medical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Medical Oncology, Catharina Cancer Centre, Eindhoven, Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Surgery, Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: · Pubmed 30413379
  • Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Data Centre, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Dutch Breast Cancer Research Group, BOOG Study Centre, IJsbaanpad 9-11, 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Deventer Ziekenhuis, Nico Bolkesteinlaan 75, 7416 SE, Deventer, The Netherlands. · Department of Medical Oncology, HagaZiekenhuis, Els Borst-Eilersplein 275, 2545 AA, The Hague, The Netherlands. · Department of Internal Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Medical Oncology, Zaans Medisch Centrum, Koningin Julianaplein 58, 1502 DV, Zaandam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Surgical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Centre, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: · Department of Medical Oncology, Haaglanden Medisch Centrum, The Hague, The Netherlands. · Pubmed 30125761
  • Department of Pathology, University Medical Center Utrecht, The Netherlands. · Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Biology and Epigenetics Group, Research Center (CI-IPOP), Portuguese Oncology Institute of Porto, Portugal. · Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Portugal. · Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, The Netherlands. · Pubmed 29972720
  • Department of Medical Oncology, VU University Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Reinier de Graaf Groep, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands. · Department of Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Centre Utrecht, and Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Pubmed 30287915
  • Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center, 3584 CX, Utrecht, The Netherlands. · Dutch Breast Cancer Research Group, (BOOG Study Center), 1076 CV, Amsterdam, The Netherlands. · Department of Medical Oncology, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands. · Cancer Genomics Netherlands, Universiteitsweg 100, 3584 CG, Utrecht, The Netherlands. · Department of Pathology, VU Medical Center (VUMC), 1081 HV, Amsterdam, The Netherlands. · Division of Oncology and Pathology, Lund University, 221 00, Lund, Sweden. · Department of Pathology, Radboud University Medical Center, 6525 GA, Nijmegen, The Netherlands. · Department of Pathology, Leiden University Medical Centre, 2333 ZA, Leiden, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, 1066 CX, The Netherlands. · Faculty of EEMCS, Delft University of Technology, 2628 CD, Delft, The Netherlands. · Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands. · Pubmed 29396493
  • Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Hpn Q05.4300, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization, PO Box 19079, 3501 DB, Utrecht, The Netherlands; Department of Health Technology & Services Research (HTSR), University of Twente, PO Box 217, Enschede 7500 AE, Enschede, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, PO Box 85500, 3508 GA, Utrecht, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 29274928
2017
  • Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., P.O. Box 19024, Seattle, USA. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX Utrecht, The Netherlands; Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; Department of Healthcare Technology and Services Research, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. Electronic address: · Pubmed 27992844
  • Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. Electronic address: · Division of Medical Oncology, GROW - School of Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, Netherlands. · Department for Health Evidence, Radboud Institute Health Sciences, Radboud University Medical Centre, Nijmegen, Netherlands. · Clinical Research Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, Netherlands. · Department of Medical Oncology, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute, Amsterdam, Netherlands. · Department of Radiation Oncology, Catharina Hospital, Eindhoven, Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, Netherlands. · Department of Medical Oncology, Medical Centre Leeuwarden, Leeuwarden, Netherlands. · Department of Medical Oncology, Isala Clinics, Zwolle, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Sittard-Geleen, Geleen, Netherlands. · Department of Medical Oncology, Zuyderland Medical Center Heerlen-Sittard-Geleen, Heerlen, Netherlands. · Department of Surgery, Gelderse Vallei Hospital, Ede, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Netherlands. · Department of Medical Oncology, Deventer Hospital, Deventer, Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. · Pubmed 29031778
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28017458
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Gelderland, Netherlands. · Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland. · Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, Gelderland, Netherlands. · Department of Pathology, ErasmusMC Cancer Institute, Rotterdam, Zuid-Holland, Netherlands. · Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Pathology, Complejo Hospitalario de Navarra, Pamplona, Spain. · Department of Pathology, IsalaKlinieken Zwolle, Zwolle, Overijssel, Netherlands. · Department of Pathology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, Netherlands. · Department of Pathology, Rion University Hospital, University of Patras, Medical School, Patras, Greece. · Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Piemonte, Italy. · Department of Medical Sciences, University of Torino, Torino, Italy. · Department of Tumor Pathology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland. · Faculty of Medicine and University Hospital, Charles University in Prague, Hradec Kralove, Czech Republic. · Departmentof Obstetrics and Gynaecology at the Catholic, Universityof Leuven, Leuven, Belgium. · Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, NetherlandsCancer Institute, Amsterdam, Noord-Holland, Netherlands. · Genomics Core Facility, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Medical Image Analysis Group (IMAG/e), Technische Universiteit Eindhoven, Eindhoven, Noord-Brabant, Netherlands. · Department of Epidemiology, Maastricht University, Maastricht, Limburg, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, Utrecht, UK. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Computational Cancer Biology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands. · Division of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands. · Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, Enschede, Overijssel, Netherlands. · Pubmed 29138205
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · University of California, San Francisco, CA, USA. · Agendia NV, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Current address: Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. · Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Division Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Pubmed 28851423
  • Netherlands Cancer Institute, Amsterdam, The Netherlands. · German Breast Group, Neu-Isenburg, Germany. · Charité - Universitätsmedizin, Berlin, Germany. · University Women's Hospital, Frankfurt, Germany. · University Clinic for Internal Medicine Oncology and Hematology, Oldenburg, Germany. · University Halle Wittenberg, Halle, Germany. · Gesellschaft für onkologische Studien, Troisdorf, Germany. · St. Josefs-Hospital, Wiesbaden, Germany. · Ev. Krankenhaus, Ludwigsfelde-Teltow, Germany. · Elisabeth Krankenhaus, Kassel, Germany. · Women's Hospital, University of Kiel, Kiel, Germany. · University Medical Center, Utrecht, The Netherlands. · Center for Gynecological Oncology at University Women's Hospital, Im Neuenheimer Feld 460, 69120, Heidelberg, Germany. · Pubmed 28822007
  • Anne Kuijer, Marieke Straver, Bianca den Dekker, Annelotte C.M. van Bommel, and Thijs van Dalen, Diakonessenhuis · Anne Kuijer, Sjoerd G. Elias, Sabine C. Linn, and Thijs van Dalen, University Medical Centre Utrecht · Sabine Siesling, Netherlands Comprehensive Cancer Organization, Utrecht · Carolien H. Smorenburg and Jelle Wesseling, Antoni van Leeuwenhoek Hospital · Carolien H. Smorenburg, Jelle Wesseling, Sabine C. Linn, and Emiel J.Th. Rutgers, Netherlands Cancer Institute, Amsterdam · and Sabine Siesling, University of Twente, Enschede, the Netherlands. · Pubmed 28813638
  • Department of Medical Decision Making, Leiden University Medical Center, Leiden, The Netherlands. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Faculty of Medical Science, Anglia Ruskin University, Cambridge, UK. · Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Biometrics Department, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Epidemiology, Maastricht University Medical Center, Maastricht, The Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands. · Laboratory Pathology East-Netherlands, Hengelo, The Netherlands. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Laboratory for Pathology, Dordrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. · University of Texas, Health Sciences Center, San Antonio, USA. · Department of Oncology, Strangeways Research Laboratory, University of Cambridge, Worts Causeway, Cambridge, UK. · Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. Electronic address: · Pubmed 28412587
  • Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Biometrics, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Amsterdam, The Netherlands. · Moores Cancer Center, University of California San Diego, San Diego, CA, USA. · Department of Pathology, University Medical Center, Utrecht, The Netherlands. · Laboratory Medicine, University of California, San Francisco, CA, USA. · Department of Pharmacy and Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute and MC Slotervaart, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. · Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands. · Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 28005246
2016
  • Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Clinical Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Universiteitsweg 99, 3584CG, Utrecht, The Netherlands. · Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Department of Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Division of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27323902
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · West German Study Group, Germany. · Breast Centre Niederrhein, Moenchengladbach, Germany. · Brustzentrum, Ludwig-Maximillian University Munich, Germany. · Universitäts-Frauenklinik Duesseldorf, Germany. · Genomics Core Facility, NKI-AVL, Amsterdam, The Netherlands. · Universitäts-Frauenklinik Lübeck, Germany. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Germany. · National Center for Tumour Diseases, University of Heidelberg, Germany. · Pubmed 26946057
  • Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Statistics Department, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands; Department of Pathology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. · Department of Surgery, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. · Department of Pathology, Academical Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. · Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: · Pubmed 27587341
  • Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Netherlands Comprehensive Cancer Organisation, Godebaldkwartier 419, 3511DT, Utrecht, The Netherlands. · Department of Molecular Pathology, Utrecht University Medical Center, Heidelberglaan 100, 3584CX, Utrecht, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands. · Pubmed 27357813
  • Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands. · Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands. · Department of Radiation Oncology, Medical Spectrum Twente, Enschede, Netherlands. · Department of Surgery, Diakonessenhuis Utrecht, Utrecht, Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, University Medical Centre Utrecht, Utrecht, Netherlands. · Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, Netherlands. · Department of Surgical Oncology, Canisius Wilhelmina Hospital, Nijmegen, Netherlands. · Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands; Department of Health Technology and Services Research, MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, Netherlands. Electronic address: · Pubmed 27344114
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Agendia NV, Amsterdam, XH, The Netherlands. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Medical Oncology, Radboud University Medical Center, Nijmegen, GA, The Netherlands. · Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, CX, The Netherlands. · Department of Pathology, University Medical Center Utrecht, CX, The Netherlands. · Pubmed 27129152
  • Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE, UK. · Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Translational Research Department, Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France. · Agendia NV, Science Park 406, 1098 XH Amsterdam, The Netherlands. · Cancer Biology and Therapeutics Laboratory, UCD School of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. · OncoMark Limited, NovaUCD, Belfield Innovation Park, Dublin 4, Ireland. · Genomic Core Facility, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Cambridge Experimental Cancer Medicine Centre (ECMR) and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Cambridge Breast Unit and Cambridge University Hospitals, NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK. · Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QP, UK. · Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 85 Lund, Sweden. · Department of Pathology, RCSI ERC, Beaumont Hospital, Dublin 9, Ireland. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, Massachusetts 02129, USA. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of EEMCS, Delft University of Technology, Delft, The Netherlands. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK. · Cancer Genomics Netherlands, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Pubmed 26729235
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · MRC Holland, Amsterdam, the Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Pubmed 26637364
2015
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam, and University Medical Center Utrecht, Utrecht, the Netherlands · Pubmed 25918281
  • Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands. Electronic address: · Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam, The Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands. · Pubmed 25997856
  • Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Electronic address: · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Biometrics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Department of Molecular Biology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. · Pubmed 26429398
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, University Medical Center Utrecht, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Data Center, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Pubmed 26355282
  • Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Agendia NV, Amsterdam, The Netherlands. · Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · CRUK Cambridge Institute, Cambridge, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden. · Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. Electronic address: · Pubmed 26004083
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Breakthrough Breast Cancer Research Unit, Department of Research Oncology, Guy's Hospital, King's College London School of Medicine, London, United Kingdom. · Division of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands; Netherlands Center for Personalized Cancer Treatment, Utrecht, The Netherlands. · Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands. · The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. · Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. · Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK; Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Experimental Cancer Medicine Centre and NIHR Cambridge Biomedical, Research Centre, Cambridge University Hospitals NHS, Cambridge, UK. · Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, The Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: · Pubmed 25825120
  • Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Universitäts-Frauenklinik, University of Heidelberg, Heidelberg, Germany. National Center for Tumour Diseases, Heidelberg, Germany. · Institute of Pathology, University of Heidelberg, Heidelberg, Germany. · Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands. · Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Pubmed 25480832
  • Netherlands Cancer Institute, Amsterdam, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University Medical Center Utrecht, Utrecht, the Netherlands. · Netherlands Cancer Institute, Amsterdam; and University of Twente, School of Governance and Management, Enschede, the Netherlands · Pubmed 25847931
2014
  • Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands. · Department of Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands. · Department of Surgery, Catharina Ziekenhuis, Eindhoven, The Netherlands. · Department of Medical Oncology, Spaarne Ziekenhuis, Hoofddorp, The Netherlands; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands. · Department of Surgery, MC Zuiderzee, Lelystad, The Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. · Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: · Pubmed 24970786
  • Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: · Department of Research and Development, Agendia, Amsterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands. · Department of Product Development and Support, Agendia, Amsterdam, the Netherlands. · Department of Medical Affairs, Agendia, Irvine, California. · Department of Medical Affairs, Agendia, Amsterdam, the Netherlands. · Department of Medical Sciences, University of Turin, Turin, Italy. · Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. · Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. · Department of Surgical Oncology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Pathology, St. Luke's Hospital and Health Network, Bethlehem, Pennsylvania. · Department of Medicine, Todd Cancer Institute, Long Beach Memorial Medical Center, Long Beach, California. · Department of Surgery, University of South Florida, Tampa, Florida. · Pubmed 24378251
2015
  • Universitair Medisch Centrum Utrecht, afd. Chirurgie, Utrecht. · Pubmed 26131746
  • *Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute/Slotervaart Hospital, Amsterdam †Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam ‡Department of Pathology, University Medical Center Utrecht, Utrecht §Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam ¶Faculty of Science, Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, the Netherlands. · Pubmed 26035041
12 Other Locations Show
Yearly article counts 3816181715164000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.